查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1919396

冠状动脉CT血管摄影检查AI医学影像软体市场：按组件、部署类型、技术、应用和最终用户划分 - 全球预测（2026-2032年）

AI Medical Imaging Software for Coronary CT Angiography Market by Component, Deployment, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，用于冠状动脉 CT血管摄影检查的 AI 医学影像软体市值将达到 16.2 亿美元，到 2026 年将成长至 17.3 亿美元，到 2032 年将达到 33.4 亿美元，复合年增长率为 10.85%。

关键市场统计数据
基准年 2025 16.2亿美元
预计年份：2026年 17.3亿美元
预测年份 2032 33.4亿美元
复合年增长率 (%) 10.85%

权威概述人工智慧驱动的冠状动脉CT血管造影软体如何变革临床工作流程、决策支援和以患者为中心的医疗服务。

人工智慧驱动的冠状动脉CT血管摄影检查医学影像解决方案正在重塑临床医生检测、量化和管理冠状动脉疾病的方式。这些技术结合了先进的影像处理、分割模型和诊断决策支持，能够缩短解读时间、提高测量一致性，并提取以往需要耗费大量人力才能获得的具有临床意义的生物标记。因此，放射科和循环系统团队能够转向更积极主动、数据驱动的工作流程，优先考虑患者风险分层和个人化治疗方案。

对融合的技术、监管和实施变革进行了深入分析，这些变革正在重新定义人工智慧心臟影像。

在人工智慧赋能的冠状动脉CT血管摄影软体领域，多项变革正在同步发生，重新定义了人们对临床表现、营运效率和供应商协作的预期。首先，深度学习和电脑视觉演算法的进步提高了病变分割和狭窄量化等任务的准确性。同时，结合基于物理的建模和数据驱动方法的混合方法提高了软体在不同扫描仪类型和患者群体中的适用性。因此，临床团队在各种成像条件下都能获得更一致的输出结果，从而促进了该技术的更广泛应用。

深入分析2025年关税政策对人工智慧心臟影像影像解决方案的采购经济性、供应链韧性和部署模式偏好的影响

2025年实施的新关税政策为医疗影像供应商和医疗系统的采购和供应链计算带来了新的复杂性。关税相关的成本压力对影像设备、运算基础设施和专用组件造成了连锁反应，进而影响供应商的定价策略和人工智慧解决方案的总体拥有成本。为此，供应商正在重新评估其筹资策略，探索本地製造伙伴关係关係，并重新设计解决方案组合，以在维持服务水准和支援的同时，降低单位成本的成长。

对组件、部署、最终用户、技术和应用领域进行详细分析，以识别不同的买家需求和产品定位策略。

了解冠状动脉CT血管摄影软体中的分割动态对于协调产品设计、商业化和临床检验策略至重要。从组件角度来看，市场分为「服务」和「解决方案」。服务包括安装/整合、维护和培训/支持，而解决方案则分为「企业软体」和「独立软体」。这种划分影响着供应商的产品包装和长期合约定价。同时，部署选项分为云端部署和本地部署，云端部署进一步细分为混合云端、私有云端和公共云端。本地部署则提供安装许可或订阅许可两种模式，每种模式在营运和管治方面都存在不同的权衡取舍。

战略区域评估揭示了美洲、欧洲、中东和非洲以及亚太市场在采用驱动因素、监管预期和商业化路径方面的差异

区域趋势将对人工智慧驱动的冠状动脉CT血管摄影检查解决方案的采纳路径、伙伴关係机会和监管要求产生重大影响。在美洲，医疗系统和专科机构优先考虑与现有影像系统和企业IT生态系统的集成，并专注于临床证据和报销机制的协调一致，以支援更广泛的临床应用。从初步试点到全系统推广，需要关注互通性标准，并清楚地展示其对临床医生和管理人员的工作流程效率。

这是一份简洁的竞争情报报告，阐述了现有企业、专业人工智慧开发商和策略性新进业者如何塑造临床应用、伙伴关係和差异化格局。

人工智慧冠状动脉CT血管摄影领域的竞争格局呈现出多元化的特点：既有成熟的医学影像供应商，也有专注于人工智慧的专业公司，还有新兴的临床软体参与企业，它们各自采取不同的策略来拓展临床应用。现有的影像平台供应商利用其庞大的用户群和成熟的分销管道，提供整合的工作流程和端到端的服务包。这些公司将互通性、临床检验伙伴关係和长期服务协议视为竞争优势，以吸引那些寻求整合供应商关係的大型医疗机构。

为供应商和医疗系统领导者提供切实可行的策略，以加速临床应用、降低风险，并使商业模式与医疗服务成果保持一致。

产业领导者应采取务实、以证据为导向的策略，在控制营运和监管风险的同时，加速临床应用。首先，应优先进行高品质的临床检验，将诊断结果与可操作的诊疗路径和可衡量的终点指标连结起来。透过将检验研究与临床医生的工作流程和支付方关注的结果相结合，各机构可以减少应用障碍，并为采购委员会建立引人注目的价值提案。

采用透明的混合方法调查方法，结合临床访谈、技术检验、文献回顾和情境分析，以确保研究结果的稳健性和可重复性。

本调查方法融合了多种研究手段，旨在对人工智慧冠状动脉CT血管摄影检查的现况进行全面且可重复的评估。主要研究包括对临床负责人、影像专家和采购主管进行结构化访谈，以了解实际工作流程的限制、检验优先顺序和采购考量。此外，还透过对产品负责人和工程师进行技术访谈，补充这些定性研究成果，以了解架构选择、实施权衡和整合挑战。

最终结论强调，实证整合、灵活实施和临床医师信心是持续推广和商业性成功的核心驱动因素。

人工智慧驱动的冠状动脉CT血管摄影软体的未来发展趋势是：更深入的临床整合、多样化的部署模式，以及对检验和管治日益增长的期望。随着演算法技术的成熟，关注点将逐渐从概念概念验证的准确性转向可证实的临床效用、在异质成像环境下的可重复性，以及与心臟病学和放射学工作流程的有效整合。这项转变需要供应商和医疗系统在证据产生、互通性和培训方面合作，以实际提高诊断一致性和病患管理水准。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 冠状动脉CT血管摄影检查AI医学影像软体市场（依组件划分）

  • 服务
    • 安装与集成
    • 维护
    • 培训和支持
  • 解决方案
    • 企业软体
    • 独立软体

9. 冠状动脉CT血管摄影检查AI医学影像软体市场（依部署方式划分）

  • 云
    • 混合云端
    • 私有云端
    • 公共云端
  • 本地部署
    • 已安装许可证
    • 订阅许可

10. 冠状动脉CT血管摄影检查人工智慧医学影像软体市场（依技术划分）

  • 电脑视觉
  • 深度学习
  • 机器学习

第十一章 冠状动脉CT血管摄影检查人工智慧医学影像软体市场（按应用领域划分）

  • 检测冠状动脉疾病
  • 斑块特征
  • 狭窄程度量化
  • 血管分析

第十二章 冠状动脉CT血管摄影检查AI医学影像软体市场（依最终用户划分）

  • 门诊治疗中心
  • 诊所
  • 诊断中心
  • 医院
    • 循环系统
    • 放射科

13. 各地区冠状动脉CT血管摄影检查AI医学影像软体市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 冠状动脉CT血管摄影检查AI医学影像软体市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国冠状动脉CT血管摄影检查AI医学影像软体市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国冠状动脉CT血管摄影检查人工智慧医学影像软体市场

第十七章：中国冠状动脉CT血管摄影检查人工智慧医学影像软体市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert Group
  • Aidoc Medical Ltd.
  • Arterys, Inc.
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CureMetrix Inc.
  • Enlitic, Inc.
  • GE HealthCare Technologies Inc.
  • HeartFlow, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • Medis Medical Imaging Systems BV
  • Qure.ai Technologies Pvt. Ltd.
  • Siemens Healthineers AG
  • VIDA Diagnostics, Inc.
  • Zebra Medical Vision Ltd.
Product Code: MRR-F14BA1B34301

The AI Medical Imaging Software for Coronary CT Angiography Market was valued at USD 1.62 billion in 2025 and is projected to grow to USD 1.73 billion in 2026, with a CAGR of 10.85%, reaching USD 3.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.62 billion
Estimated Year [2026] USD 1.73 billion
Forecast Year [2032] USD 3.34 billion
CAGR (%) 10.85%

An authoritative overview of how AI-enabled coronary CT angiography software is transforming clinical workflows, decision support, and patient-centric cardiac care delivery

AI-driven medical imaging solutions for coronary CT angiography are reshaping how clinicians detect, quantify, and manage coronary artery disease. These technologies combine advanced image processing, segmentation models, and diagnostic decision support to accelerate review times, enhance measurement consistency, and surface clinically relevant biomarkers that were previously labor-intensive to extract. As a result, radiology and cardiology teams can shift toward more proactive, data-driven workflows that prioritize patient risk stratification and personalized care planning.

The convergence of high-resolution CT acquisition, iterative reconstruction techniques, and machine learning algorithms has created a fertile environment for software that offers automated plaque characterization, stenosis quantification, and vessel analysis. Moreover, growing acceptance of software-as-a-medical-device paradigms and the emergence of cloud-based clinical platforms have increased the points of integration across imaging, reporting, and downstream clinical systems. Consequently, decision-makers must evaluate not only algorithm performance but also integration pathways, data governance, and clinical validation strategies to ensure seamless adoption.

Moving forward, stakeholders ranging from hospital IT leaders to frontline cardiologists will prioritize solutions that demonstrate reproducible clinical value, streamlined interoperability, and transparent algorithm behavior. In this context, procurement and R&D teams should focus on end-to-end clinical workflow alignment and evidence generation that supports both regulatory clearance and payer acceptance. Ultimately, the most successful solutions will balance technological sophistication with pragmatic deployment and clinician-centric design.

Compelling analysis of converging technological, regulatory, and deployment shifts that are redefining clinical expectations, integration demands, and adoption pathways for AI cardiac imaging

The landscape for AI-enabled coronary CT angiography software is undergoing multiple transformative shifts that together are redefining expectations for clinical performance, operational efficiency, and vendor engagement. First, algorithmic advances in deep learning and computer vision have increased accuracy for tasks such as lesion segmentation and stenosis quantification, while hybrid approaches that blend physics-aware modeling with data-driven methods are improving generalizability across scanner types and patient populations. Consequently, clinical teams are seeing more consistent outputs across diverse imaging conditions, which supports broader adoption.

Second, deployment models are shifting toward flexible architectures that include cloud-native platforms, private and hybrid cloud options, and on-premise installations with modern subscription licensing. This evolution enables health systems to balance data residency requirements with the scalability and continuous update cadence that AI models require. At the same time, integration into enterprise imaging ecosystems, electronic health records, and reporting workflows is becoming a baseline expectation rather than a differentiator, prompting vendors to provide robust APIs and standardized interoperability profiles.

Third, regulatory scrutiny and the need for explainability are prompting vendors to invest in transparent model documentation, clinical validation studies, and post-market surveillance mechanisms. These investments are not purely compliance exercises; they directly affect clinician trust and the speed at which solutions move from pilot projects to routine use. Finally, reimbursement landscapes and stakeholder incentives are encouraging tighter alignment between diagnostic outputs and care pathways, ensuring that software not only identifies pathology but also supports actionable clinical decisions and measurable outcomes.

An incisive assessment of how 2025 tariff policies are reshaping procurement economics, supply chain resilience, and deployment model preferences for AI cardiac imaging solutions

The introduction of new tariff policies in 2025 has introduced renewed complexity into the procurement and supply chain calculus for medical imaging vendors and health systems. Tariff-related cost pressures on imaging hardware, compute infrastructure, and certain specialized components have cascading effects on vendor pricing strategies and the total cost of ownership for AI-enabled solutions. In response, vendors are reassessing sourcing strategies, exploring local manufacturing partnerships, and redesigning solution bundles to mitigate unit-cost increases while preserving service levels and support commitments.

These trade policy dynamics also influence deployment choices. Health systems that face higher import-related hardware costs may favor cloud-based services or subscription models that reduce upfront capital expenditures and shift costs toward operating expenses. Conversely, organizations with stringent data residency or regulatory constraints may accelerate investments in on-premise or private-cloud architectures despite higher initial costs, prioritizing control over latency and governance. As a result, product roadmaps and commercial terms must be flexible to accommodate both capital-constrained buyers and institutions prioritizing sovereignty.

Furthermore, tariff-driven supply chain realignments are catalyzing regional partnerships and nearshoring initiatives that can shorten lead times and enhance resilience. Vendors with diversified manufacturing footprints or those that invest in modular, software-centric solutions will be better positioned to buffer clients from policy volatility. Ultimately, stakeholders should account for these macroeconomic shifts when negotiating long-term contracts, service-level agreements, and multi-year deployment plans to ensure predictable clinical continuity.

A granular unpacking of component, deployment, end-user, technology, and application segmentation that clarifies distinct buyer needs and product positioning strategies

Understanding segmentation dynamics is essential to aligning product design, commercialization, and clinical validation strategies for coronary CT angiography software. From a component perspective, the market divides between services and solutions, where services encompass installation and integration, maintenance, and training and support, and solutions bifurcate into enterprise software and standalone software; this split informs how vendors package offerings and price long-term engagements. In parallel, deployment choices range from cloud and on-premise models, with the cloud route further differentiated into hybrid cloud, private cloud, and public cloud options, while on-premise implementations are delivered through installed licenses or subscription licenses, each presenting different operational and governance trade-offs.

End-user segmentation reveals distinct adoption pathways and workflow needs across ambulatory centers, clinics, diagnostic centers, and hospitals, with hospitals requiring tighter integration with cardiology departments and radiology departments to support multidisciplinary care. Technology segmentation emphasizes the role of computer vision, deep learning, and machine learning approaches in solving specific imaging challenges and in meeting expectations for explainability and performance. Application-based segmentation focuses attention on clinical use cases such as coronary artery disease detection, plaque characterization, stenosis quantification, and vessel analysis, and each application carries unique validation, regulatory, and usability requirements.

Taken together, these segmentation layers underscore the necessity of tailored value propositions: enterprise-focused solutions must emphasize scalability, governance, and enterprise integration; standalone tools should prioritize ease of deployment and direct clinical utility; cloud offerings need to address data privacy and continuous delivery; and on-premise options must balance performance with control. By mapping product features to the nuanced needs of different end users and applications, vendors can accelerate clinical uptake and optimize commercial trajectories.

A strategic regional assessment illuminating how Americas, Europe Middle East & Africa, and Asia-Pacific markets diverge in adoption drivers, regulatory expectations, and commercialization pathways

Regional dynamics strongly influence adoption pathways, partnership opportunities, and regulatory expectations for AI-driven coronary CT angiography solutions. In the Americas, healthcare systems and specialty centers often prioritize integration with existing imaging and enterprise IT ecosystems, coupled with a focus on clinical evidence and reimbursement alignment that supports wider clinical adoption. Moving from early pilots to system-wide deployments requires attention to interoperability standards and clear demonstration of workflow efficiency gains to clinicians and administrators alike.

Across Europe, Middle East & Africa, regulatory harmonization, data protection frameworks, and diverse payer structures create a mosaic of requirements that vendors must navigate. Successful market approaches in this region emphasize localized clinical validation, multilingual interfaces, and flexible deployment options that accommodate varying infrastructure maturity. Meanwhile, Asia-Pacific markets demonstrate a blend of rapid technology uptake in major urban centers and a pragmatic approach to hybrid deployment models that balance cloud scalability with on-premise data governance. Vendors entering these markets will benefit from regional partnerships and tailored go-to-market strategies that reflect local procurement cycles, clinical pathways, and infrastructure constraints.

Across all regions, clinical trust, evidence generation, and culturally attuned change management remain essential. Regional differences in scanner prevalence, clinical training models, and health system incentives mean that a one-size-fits-all commercialization plan is unlikely to succeed. Instead, regional strategies should combine standardized technical capabilities with local adaptations in clinical validation, service delivery, and stakeholder engagement.

A concise competitive intelligence narrative describing how incumbents, specialized AI developers, and strategic newcomers are shaping clinical adoption, partnerships, and differentiation

Competitive dynamics in the AI coronary CT angiography space are defined by a mix of established medical imaging vendors, specialized AI companies, and emerging clinical software entrants, each pursuing differentiated routes to capture clinical traction. Incumbent imaging platform providers leverage installed bases and established distribution channels to offer integrated workflows and end-to-end service packages. These players often compete on interoperability, clinical validation partnerships, and long-term service agreements that appeal to large health systems seeking consolidated vendor relationships.

Specialized AI vendors focus on rapid innovation cycles, niche clinical excellence, and algorithmic performance in targeted applications such as plaque characterization or stenosis quantification. These firms typically emphasize clinical trial evidence, peer-reviewed validation, and flexible deployment models to enter hospitals and diagnostic centers. Emerging entrants often adopt partnership strategies with modality manufacturers, cloud providers, or healthcare systems to accelerate access to clinical data and deployment scale. They also differentiate through user-centered design and clinician-friendly reporting tools that reduce cognitive burden and speed diagnostic workflows.

Across the competitive landscape, strategic partnerships, regulatory clearances, and evidence of clinical impact are the primary differentiators. Organizations that combine rigorous validation with scalable commercial models and robust post-market support will have an advantage in building clinician trust and securing long-term contracts. Observability into model performance and a commitment to continuous improvement are increasingly table stakes for sustained market relevance.

Actionable strategy recommendations for vendors and health system leaders to accelerate clinical adoption, mitigate risk, and align commercial models with care delivery outcomes

Industry leaders should adopt pragmatic, evidence-centered strategies that accelerate clinical adoption while managing operational and regulatory risks. First, prioritize high-quality clinical validation that ties diagnostic outputs to actionable care pathways and measurable endpoints. By aligning validation studies with clinician workflows and payer-relevant outcomes, organizations can reduce adoption friction and build a compelling value case for procurement committees.

Second, design deployment flexibility into product roadmaps by offering hybrid cloud, private cloud, public cloud, and robust on-premise options with clear data governance controls. This approach enables health systems to choose models that match their risk tolerance and IT investment strategies. Third, invest in clinician engagement through role-specific training, integrated reporting templates for cardiology and radiology teams, and in-situ support during initial rollouts to accelerate clinician confidence and reduce workflow disruption.

Fourth, strengthen commercial resilience by diversifying supply chains and exploring regional manufacturing or partnership models to mitigate tariff and policy exposure. Fifth, commit to transparent model documentation, post-market monitoring, and explainability features that support regulatory compliance and clinician trust. Finally, pursue customer-centric pricing and licensing strategies, including outcome-aligned contracts and flexible subscription terms, to lower barriers for pilots scaling into enterprise deployments.

A transparent mixed-methods research approach combining clinical interviews, technical validation, literature synthesis, and scenario analysis to ensure robust and reproducible insights

The research methodology integrates mixed methods to provide a comprehensive and reproducible assessment of the AI coronary CT angiography landscape. Primary research combines structured interviews with clinical leaders, imaging specialists, and procurement executives to capture real-world workflow constraints, validation priorities, and purchasing considerations. These qualitative inputs are complemented by targeted technical interviews with product leaders and engineers to understand architecture choices, deployment trade-offs, and integration challenges.

Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, and technical documentation to verify algorithmic approaches, validation study designs, and reported performance metrics. The methodology emphasizes triangulation: insights from interviews are cross-validated against published evidence and vendor disclosures to minimize bias and ensure factual accuracy. In addition, case studies of representative deployments are analyzed to extract lessons on change management, service delivery, and clinician uptake.

Analytical frameworks assess segmentation across components, deployment models, end users, technologies, and applications to reveal differential adoption pathways and feature priorities. Scenario analysis explores how macro factors such as tariff shifts, regulatory updates, and infrastructure constraints influence strategic choices. Throughout, data governance and ethical considerations are central, ensuring that conclusions reflect both technical performance and the practical requirements for safe, equitable clinical deployment.

A decisive conclusion emphasizing evidence-driven integration, flexible deployment, and clinician trust as the core enablers of sustained adoption and commercial success

The trajectory for AI-enabled coronary CT angiography software points toward deeper clinical integration, nuanced deployment models, and heightened expectations for validation and governance. As algorithmic techniques mature, the focus will increasingly shift from proof-of-concept accuracy to demonstrable clinical utility, reproducibility across heterogeneous imaging environments, and the ability to integrate meaningfully into cardiology and radiology workflows. This shift necessitates that vendors and health systems collaborate on evidence generation, interoperability, and training to realize tangible improvements in diagnostic consistency and patient management.

Moreover, commercial success will hinge on flexible delivery models that respect data residency and governance while offering the operational benefits of cloud-native continuous improvement. Tariff-driven supply chain considerations and regional regulatory heterogeneity further underscore the need for adaptable manufacturing and commercialization strategies. Finally, stakeholder trust-fostered through transparent model behavior, rigorous post-market surveillance, and clinician-centric design-will be the decisive factor in converting pilot deployments into standard care pathways.

In summary, the most resilient products will be those that combine robust technical performance with pragmatic deployment choices, strong clinical evidence, and a commitment to ongoing support and monitoring. Organizations that adopt this holistic approach will be best positioned to convert technical innovation into sustained clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI Medical Imaging Software for Coronary CT Angiography Market, by Component

  • 8.1. Services
    • 8.1.1. Installation and Integration
    • 8.1.2. Maintenance
    • 8.1.3. Training and Support
  • 8.2. Solutions
    • 8.2.1. Enterprise Software
    • 8.2.2. Standalone Software

9. AI Medical Imaging Software for Coronary CT Angiography Market, by Deployment

  • 9.1. Cloud
    • 9.1.1. Hybrid Cloud
    • 9.1.2. Private Cloud
    • 9.1.3. Public Cloud
  • 9.2. On Premise
    • 9.2.1. Installed License
    • 9.2.2. Subscription License

10. AI Medical Imaging Software for Coronary CT Angiography Market, by Technology

  • 10.1. Computer Vision
  • 10.2. Deep Learning
  • 10.3. Machine Learning

11. AI Medical Imaging Software for Coronary CT Angiography Market, by Application

  • 11.1. Coronary Artery Disease Detection
  • 11.2. Plaque Characterization
  • 11.3. Stenosis Quantification
  • 11.4. Vessel Analysis

12. AI Medical Imaging Software for Coronary CT Angiography Market, by End User

  • 12.1. Ambulatory Centers
  • 12.2. Clinics
  • 12.3. Diagnostic Centers
  • 12.4. Hospitals
    • 12.4.1. Cardiology Departments
    • 12.4.2. Radiology Departments

13. AI Medical Imaging Software for Coronary CT Angiography Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. AI Medical Imaging Software for Coronary CT Angiography Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. AI Medical Imaging Software for Coronary CT Angiography Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States AI Medical Imaging Software for Coronary CT Angiography Market

17. China AI Medical Imaging Software for Coronary CT Angiography Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agfa-Gevaert Group
  • 18.6. Aidoc Medical Ltd.
  • 18.7. Arterys, Inc.
  • 18.8. Canon Medical Systems Corporation
  • 18.9. Carestream Health, Inc.
  • 18.10. CureMetrix Inc.
  • 18.11. Enlitic, Inc.
  • 18.12. GE HealthCare Technologies Inc.
  • 18.13. HeartFlow, Inc.
  • 18.14. Koninklijke Philips N.V.
  • 18.15. McKesson Corporation
  • 18.16. Medis Medical Imaging Systems B.V.
  • 18.17. Qure.ai Technologies Pvt. Ltd.
  • 18.18. Siemens Healthineers AG
  • 18.19. VIDA Diagnostics, Inc.
  • 18.20. Zebra Medical Vision Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY INSTALLATION AND INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY INSTALLATION AND INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY INSTALLATION AND INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TRAINING AND SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TRAINING AND SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TRAINING AND SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ENTERPRISE SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ENTERPRISE SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ENTERPRISE SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY STANDALONE SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY STANDALONE SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY STANDALONE SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY INSTALLED LICENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY INSTALLED LICENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY INSTALLED LICENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SUBSCRIPTION LICENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SUBSCRIPTION LICENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SUBSCRIPTION LICENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY MACHINE LEARNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY MACHINE LEARNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CORONARY ARTERY DISEASE DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CORONARY ARTERY DISEASE DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CORONARY ARTERY DISEASE DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY STENOSIS QUANTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY STENOSIS QUANTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY STENOSIS QUANTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY VESSEL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY VESSEL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY VESSEL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CARDIOLOGY DEPARTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY RADIOLOGY DEPARTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY RADIOLOGY DEPARTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY RADIOLOGY DEPARTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 196. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 199. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 200. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GCC AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 229. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 232. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 233. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. G7 AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 240. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 243. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 244. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 245. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. NATO AI MEDICAL IMAGING SOFTWARE FOR CORONARY CT ANGIOGRAPHY MARKET S